Ad is loading...
FSSNX
Price
$30.08
Change
+$0.54 (+1.83%)
Updated
Nov 22 closing price
VVERX
Price
$9.03
Change
+$0.13 (+1.46%)
Updated
Nov 22 closing price
Ad is loading...

FSSNX vs VVERX

Header iconFSSNX vs VVERX Comparison
Open Charts FSSNX vs VVERXBanner chart's image
Fidelity Small Cap Index
Price$30.08
Change+$0.54 (+1.83%)
VolumeN/A
CapitalizationN/A
Virtus Ceredex Small-Cap Value Eq R6
Price$9.03
Change+$0.13 (+1.46%)
VolumeN/A
CapitalizationN/A
FSSNX vs VVERX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. VVERX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Buy and VVERX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 26.9B vs. VVERX (119M). VVERX pays higher dividends than FSSNX: VVERX (3.24) vs FSSNX (1.36). FSSNX was incepted earlier than VVERX: FSSNX (13 years) vs VVERX (6 years). VVERX is a more actively managed with annual turnover of: 94.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than VVERX: FSSNX (0) vs VVERX (2500000). FSSNX annual gain was more profitable for investors over the last year : 36.08 vs. VVERX (16.95). FSSNX return over 5 years is better than : 54.79 vs. VVERX (-4.22).
FSSNXVVERXFSSNX / VVERX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years6 years-
Gain YTD20.28915.885128%
Front LoadN/AN/A-
Min. Initial Investment02500000-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B119M22,605%
Annual Yield % from dividends1.363.2442%
Returns for 1 year36.0816.95213%
Returns for 3 years5.63-25.93-22%
Returns for 5 years54.79-4.22-1,298%
Returns for 10 years94.28N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI0.850.07
+8.67%
Karyopharm Therapeutics
PTPI0.270.01
+5.02%
Petros Pharmaceuticals
LGND119.192.64
+2.27%
Ligand Pharmaceuticals
TXO18.240.23
+1.28%
TXO Partners LP
RVMD56.75-0.03
-0.05%
Revolution Medicines